{"blog": [], "keywords": [{"value": "Theranos Inc", "name": "organizations", "rank": "1", "is_major": "Y"}, {"value": "Venture Capital", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Walgreen Co.", "name": "organizations", "rank": "3", "is_major": "Y"}, {"value": "Tests (Medical)", "name": "subject", "rank": "4", "is_major": "Y"}, {"value": "Blood", "name": "subject", "rank": "5", "is_major": "Y"}, {"value": "Start-ups", "name": "subject", "rank": "6", "is_major": "N"}, {"value": "Holmes, Elizabeth (1984- )", "name": "persons", "rank": "7", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/04/27/opinion/dont-blame-silicon-valley-for-theranos.html", "document_type": "article", "byline": {"person": [{"lastname": "STROSS", "firstname": "Randall", "role": "reported", "organization": "", "rank": 1}], "original": "By RANDALL STROSS"}, "type_of_material": "Op-Ed", "multimedia": [{"url": "images/2016/04/27/opinion/27strossWeb/27strossWeb-thumbWide.jpg", "legacy": {"wide": "images/2016/04/27/opinion/27strossWeb/27strossWeb-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/04/27/opinion/27strossWeb/27strossWeb-articleLarge-v2.jpg", "legacy": {"xlarge": "images/2016/04/27/opinion/27strossWeb/27strossWeb-articleLarge-v2.jpg", "xlargeheight": "429", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 429}, {"url": "images/2016/04/27/opinion/27strossWeb/27strossWeb-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/04/27/opinion/27strossWeb/27strossWeb-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Opinion", "word_count": "873", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "The troubled testing company dazzled the media, but Palo Alto investors were the first to see the potential flaws.", "pub_date": "2016-04-27T00:00:00Z", "news_desk": "OpEd", "headline": {"kicker": "Op-Ed Contributor", "print_headline": "Theranos Isn\u2019t Silicon Valley\u2019s Fault", "main": "Don\u2019t Blame Silicon Valley for Theranos", "content_kicker": "Op-Ed Contributor"}, "print_page": "23", "snippet": "The troubled testing company dazzled the media, but Palo Alto investors were the first to see the potential flaws.", "_id": "5720686138f0d82fc1b0ffa4", "slideshow_credits": null, "abstract": "Op-Ed article by author Randall Stross contradicts those who would portray turmoil surrounding medical diagnostics start-up Theranos as typical case of irresponsible Silicon Valley hype; holds seasoned investors saw early red flags in company's methods but Walgreens, eager like many old-world companies to acquire small innovators, seized chance for lucrative investment.  "}